35.4
Arcadia Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
25.4
FY23:
15.0
FY24:
9.24
FY25:
6.36
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.53
FY22:
3.52
FY23:
4.73
FY24:
4.28
FY25:
0.19
Total assets
Change from FY21 to FY25
millions USD
FY21:
43.9
FY22:
28.9
FY23:
19.7
FY24:
13.5
FY25:
6.55
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.04
FY22:
4.21
FY23:
3.59
FY24:
2.56
FY25:
2.06
(negative)
Change from FY21 to FY25
millions USD
FY21:
7.68
FY22:
3.81
FY23:
3.41
FY24:
4.73
FY25:
0.35
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.1
FY22:
21.0
FY23:
12.8
FY24:
6.22
FY25:
4.14
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
43.8
FY22:
29.1
FY23:
19.8
FY24:
13.5
FY25:
6.55
All amounts in millions USD